399 related articles for article (PubMed ID: 20707314)
1. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus.
Zoraghi R; See RH; Gong H; Lian T; Swayze R; Finlay BB; Brunham RC; McMaster WR; Reiner NE
Biochemistry; 2010 Sep; 49(35):7733-47. PubMed ID: 20707314
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from Plasmodium falciparum.
Chan M; Sim TS
Biochem Biophys Res Commun; 2005 Jan; 326(1):188-96. PubMed ID: 15567170
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
4. The quaternary structure of pyruvate kinase type 1 from Escherichia coli at low nanomolar concentrations.
Zhu T; Bailey MF; Angley LM; Cooper TF; Dobson RC
Biochimie; 2010 Jan; 92(1):116-20. PubMed ID: 19800933
[TBL] [Abstract][Full Text] [Related]
5. ATP-dependent 6-phosphofructokinase from the hyperthermophilic bacterium Thermotoga maritima: characterization of an extremely thermophilic, allosterically regulated enzyme.
Hansen T; Musfeldt M; Schönheit P
Arch Microbiol; 2002 May; 177(5):401-9. PubMed ID: 11976749
[TBL] [Abstract][Full Text] [Related]
6. Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents.
Kumar NS; Amandoron EA; Cherkasov A; Finlay BB; Gong H; Jackson L; Kaur S; Lian T; Moreau A; Labrière C; Reiner NE; See RH; Strynadka NC; Thorson L; Wong EW; Worrall L; Zoraghi R; Young RN
Bioorg Med Chem; 2012 Dec; 20(24):7069-82. PubMed ID: 23141418
[TBL] [Abstract][Full Text] [Related]
7. Entamoeba histolytica: kinetic and molecular evidence of a previously unidentified pyruvate kinase.
Saavedra E; Olivos A; Encalada R; Moreno-Sánchez R
Exp Parasitol; 2004; 106(1-2):11-21. PubMed ID: 15013784
[TBL] [Abstract][Full Text] [Related]
8. Proton donor in yeast pyruvate kinase: chemical and kinetic properties of the active site Thr 298 to Cys mutant.
Susan-Resiga D; Nowak T
Biochemistry; 2004 Dec; 43(48):15230-45. PubMed ID: 15568816
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and allosteric consequences of mutations in the subunit and domain interfaces and the allosteric site of yeast pyruvate kinase.
Fenton AW; Blair JB
Arch Biochem Biophys; 2002 Jan; 397(1):28-39. PubMed ID: 11747307
[TBL] [Abstract][Full Text] [Related]
10. Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
Zoraghi R; See RH; Axerio-Cilies P; Kumar NS; Gong H; Moreau A; Hsing M; Kaur S; Swayze RD; Worrall L; Amandoron E; Lian T; Jackson L; Jiang J; Thorson L; Labriere C; Foster L; Brunham RC; McMaster WR; Finlay BB; Strynadka NC; Cherkasov A; Young RN; Reiner NE
Antimicrob Agents Chemother; 2011 May; 55(5):2042-53. PubMed ID: 21357306
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional energetic linkages in allosteric regulation of muscle pyruvate kinase.
Lee JC; Herman P
Methods Enzymol; 2011; 488():185-217. PubMed ID: 21195229
[TBL] [Abstract][Full Text] [Related]
12. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase.
Axerio-Cilies P; See RH; Zoraghi R; Worral L; Lian T; Stoynov N; Jiang J; Kaur S; Jackson L; Gong H; Swayze R; Amandoron E; Kumar NS; Moreau A; Hsing M; Strynadka NC; McMaster WR; Finlay BB; Foster LJ; Young RN; Reiner NE; Cherkasov A
ACS Chem Biol; 2012 Feb; 7(2):350-9. PubMed ID: 22066782
[TBL] [Abstract][Full Text] [Related]
13. Metal-ion-mediated allosteric triggering of yeast pyruvate kinase. 2. A multidimensional thermodynamic linked-function analysis.
Mesecar AD; Nowak T
Biochemistry; 1997 Jun; 36(22):6803-13. PubMed ID: 9184163
[TBL] [Abstract][Full Text] [Related]
14. Catalytic mechanism and cofactor preference of dihydrodipicolinate reductase from methicillin-resistant Staphylococcus aureus.
Dommaraju SR; Dogovski C; Czabotar PE; Hor L; Smith BJ; Perugini MA
Arch Biochem Biophys; 2011 Aug; 512(2):167-74. PubMed ID: 21704017
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.
Dombrauckas JD; Santarsiero BD; Mesecar AD
Biochemistry; 2005 Jul; 44(27):9417-29. PubMed ID: 15996096
[TBL] [Abstract][Full Text] [Related]
16. Allostery in rabbit pyruvate kinase: development of a strategy to elucidate the mechanism.
Friesen RH; Castellani RJ; Lee JC; Braun W
Biochemistry; 1998 Nov; 37(44):15266-76. PubMed ID: 9799487
[TBL] [Abstract][Full Text] [Related]
17. Kinetic properties of pyruvate kinase in human maternal leukocytes in fetal malnutrition.
Mameesh MS; Metcoff J; Costiloe P; Crosby W
Pediatr Res; 1976 Jun; 10(6):561-5. PubMed ID: 1272633
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
[TBL] [Abstract][Full Text] [Related]
19. Metal-ion-mediated allosteric triggering of yeast pyruvate kinase. 1. A multidimensional kinetic linked-function analysis.
Mesecar AD; Nowak T
Biochemistry; 1997 Jun; 36(22):6792-802. PubMed ID: 9184162
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase.
Wooll JO; Friesen RH; White MA; Watowich SJ; Fox RO; Lee JC; Czerwinski EW
J Mol Biol; 2001 Sep; 312(3):525-40. PubMed ID: 11563914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
